Pritty Patel
Global Director, Microbiology, Vaccines and Novel Immunotherapeutics
Pritty Patel provides global leadership and direction in developing Labcorp Central Laboratory Services’ capabilities in clinical microbiology for anti-infective studies while also leading the continuous development of the science, strategy and breadth of departmental capabilities. She continues to develop and implement scientific and business strategy for Labcorp Central Labs’ global clinical microbiology laboratories for Phase II and III clinical trials. Additionally, Pritty is responsible for implementing quality action plans.
Pritty has more than 20 years of experience in microbiology and related fields, while achieving significant improvements in delivery and quality of testing services for clients. She presents numerous abstracts and other presentations at industry conferences on microbiology and related topics. Pritty is a member of the American Society for Microbiology and the South Central Association for Clinical Microbiology. She joined Labcorp Drug Development in 2001.